Status:

WITHDRAWN

Triadic Interactions of Families With Autism and Oxytocin

Lead Sponsor:

University of California, San Francisco

Conditions:

Autism Disorder

Eligibility:

All Genders

7-60 years

Phase:

PHASE1

Brief Summary

The study will investigate the effects of an intranasal administration of oxytocin (OT) to parents of children with autism spectrum disorders (ASD) on the quality of mother-father-child interactions. ...

Detailed Description

Autism spectrum disorder (ASD) is a continuum of neurodevelopmental disorders associated with significant communication, social, and behavioral deficits including impairments in verbal and nonverbal c...

Eligibility Criteria

Inclusion

  • For parents of patients with ASD and TD controls:
  • Age between 25 and 60 years old
  • Live with child
  • Read and communicate in English
  • For patient with ASD:
  • Age between 7 and 12 years old
  • Lives with parents
  • Has diagnosis of autism spectrum disorder, pervasive developmental disorder, or pervasive developmental disorder-not otherwise specified(PDD-NOS)
  • Communicates in English
  • Has IQ at or above 75
  • For TD controls:
  • Age between 7 and 12 years
  • Lives with parents

Exclusion

  • For parents of patients with ASD and TD controls:
  • Female parents who state they are pregnant or have a positive pregnancy test
  • Severe psychiatric, neurologic or medical illness
  • Severe nasal pathology, atrophic rhinitis, recurrent nose bleeds, or history of cranial-surgical procedures (hypophysectomy)
  • History of severe psychiatric diagnosis including schizophrenia, bipolar, and autism
  • Divorce or separation
  • Hypertension, pacemaker, cardiovascular medications
  • For patients with ASD:
  • IQ lower than 75
  • For TD controls:
  • Current psychiatric illness or developmental disability
  • Current psychiatric medication

Key Trial Info

Start Date :

August 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2015

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01912378

Start Date

August 1 2013

End Date

May 1 2015

Last Update

January 16 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California, San Francisco

San Francisco, California, United States, 94118